Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
<h4>Introduction</h4>MicroRNAs (miRNAs, miRs) are a class of small, non-coding RNA molecules with relevance as regulators of gene expression thereby affecting crucial processes in cancer development. MiRNAs offer great potential as biomarkers for cancer detection due to their remarkable...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2012
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/7ffd56597d53499ebe1fe670980c7936 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:7ffd56597d53499ebe1fe670980c7936 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:7ffd56597d53499ebe1fe670980c79362021-11-18T07:30:51ZCirculating micro-RNAs as potential blood-based markers for early stage breast cancer detection.1932-620310.1371/journal.pone.0029770https://doaj.org/article/7ffd56597d53499ebe1fe670980c79362012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22242178/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Introduction</h4>MicroRNAs (miRNAs, miRs) are a class of small, non-coding RNA molecules with relevance as regulators of gene expression thereby affecting crucial processes in cancer development. MiRNAs offer great potential as biomarkers for cancer detection due to their remarkable stability in blood and their characteristic expression in many different diseases. We investigated whether microarray-based miRNA profiling on whole blood could discriminate between early stage breast cancer patients and healthy controls.<h4>Methods</h4>We performed microarray-based miRNA profiling on whole blood of 48 early stage breast cancer patients at diagnosis along with 57 healthy individuals as controls. This was followed by a real-time semi-quantitative Polymerase Chain Reaction (RT-qPCR) validation in a separate cohort of 24 early stage breast cancer patients from a breast cancer screening unit and 24 age matched controls using two differentially expressed miRNAs (miR-202, miR-718).<h4>Results</h4>Using the significance level of p<0.05, we found that 59 miRNAs were differentially expressed in whole blood of early stage breast cancer patients compared to healthy controls. 13 significantly up-regulated miRNAs and 46 significantly down-regulated miRNAs in our microarray panel of 1100 miRNAs and miRNA star sequences could be detected. A set of 240 miRNAs that was evaluated by radial basis function kernel support vector machines and 10-fold cross validation yielded a specificity of 78.8%, and a sensitivity of 92.5%, as well as an accuracy of 85.6%. Two miRNAs were validated by RT-qPCR in an independent cohort. The relative fold changes of the RT-qPCR validation were in line with the microarray data for both miRNAs, and statistically significant differences in miRNA-expression were found for miR-202.<h4>Conclusions</h4>MiRNA profiling in whole blood has potential as a novel method for early stage breast cancer detection, but there are still challenges that need to be addressed to establish these new biomarkers in clinical use.Michael G SchrauderReiner StrickRüdiger Schulz-WendtlandPamela L StrisselLaura KahmannChristian R LoehbergMichael P LuxSebastian M JudArndt HartmannAlexander HeinChristian M BayerMayada R BaniSwetlana RichterBoris R AdamietzEvelyn WenkelClaudia RauhMatthias W BeckmannPeter A FaschingPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 1, p e29770 (2012) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Michael G Schrauder Reiner Strick Rüdiger Schulz-Wendtland Pamela L Strissel Laura Kahmann Christian R Loehberg Michael P Lux Sebastian M Jud Arndt Hartmann Alexander Hein Christian M Bayer Mayada R Bani Swetlana Richter Boris R Adamietz Evelyn Wenkel Claudia Rauh Matthias W Beckmann Peter A Fasching Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. |
| description |
<h4>Introduction</h4>MicroRNAs (miRNAs, miRs) are a class of small, non-coding RNA molecules with relevance as regulators of gene expression thereby affecting crucial processes in cancer development. MiRNAs offer great potential as biomarkers for cancer detection due to their remarkable stability in blood and their characteristic expression in many different diseases. We investigated whether microarray-based miRNA profiling on whole blood could discriminate between early stage breast cancer patients and healthy controls.<h4>Methods</h4>We performed microarray-based miRNA profiling on whole blood of 48 early stage breast cancer patients at diagnosis along with 57 healthy individuals as controls. This was followed by a real-time semi-quantitative Polymerase Chain Reaction (RT-qPCR) validation in a separate cohort of 24 early stage breast cancer patients from a breast cancer screening unit and 24 age matched controls using two differentially expressed miRNAs (miR-202, miR-718).<h4>Results</h4>Using the significance level of p<0.05, we found that 59 miRNAs were differentially expressed in whole blood of early stage breast cancer patients compared to healthy controls. 13 significantly up-regulated miRNAs and 46 significantly down-regulated miRNAs in our microarray panel of 1100 miRNAs and miRNA star sequences could be detected. A set of 240 miRNAs that was evaluated by radial basis function kernel support vector machines and 10-fold cross validation yielded a specificity of 78.8%, and a sensitivity of 92.5%, as well as an accuracy of 85.6%. Two miRNAs were validated by RT-qPCR in an independent cohort. The relative fold changes of the RT-qPCR validation were in line with the microarray data for both miRNAs, and statistically significant differences in miRNA-expression were found for miR-202.<h4>Conclusions</h4>MiRNA profiling in whole blood has potential as a novel method for early stage breast cancer detection, but there are still challenges that need to be addressed to establish these new biomarkers in clinical use. |
| format |
article |
| author |
Michael G Schrauder Reiner Strick Rüdiger Schulz-Wendtland Pamela L Strissel Laura Kahmann Christian R Loehberg Michael P Lux Sebastian M Jud Arndt Hartmann Alexander Hein Christian M Bayer Mayada R Bani Swetlana Richter Boris R Adamietz Evelyn Wenkel Claudia Rauh Matthias W Beckmann Peter A Fasching |
| author_facet |
Michael G Schrauder Reiner Strick Rüdiger Schulz-Wendtland Pamela L Strissel Laura Kahmann Christian R Loehberg Michael P Lux Sebastian M Jud Arndt Hartmann Alexander Hein Christian M Bayer Mayada R Bani Swetlana Richter Boris R Adamietz Evelyn Wenkel Claudia Rauh Matthias W Beckmann Peter A Fasching |
| author_sort |
Michael G Schrauder |
| title |
Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. |
| title_short |
Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. |
| title_full |
Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. |
| title_fullStr |
Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. |
| title_full_unstemmed |
Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. |
| title_sort |
circulating micro-rnas as potential blood-based markers for early stage breast cancer detection. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2012 |
| url |
https://doaj.org/article/7ffd56597d53499ebe1fe670980c7936 |
| work_keys_str_mv |
AT michaelgschrauder circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection AT reinerstrick circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection AT rudigerschulzwendtland circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection AT pamelalstrissel circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection AT laurakahmann circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection AT christianrloehberg circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection AT michaelplux circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection AT sebastianmjud circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection AT arndthartmann circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection AT alexanderhein circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection AT christianmbayer circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection AT mayadarbani circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection AT swetlanarichter circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection AT borisradamietz circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection AT evelynwenkel circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection AT claudiarauh circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection AT matthiaswbeckmann circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection AT peterafasching circulatingmicrornasaspotentialbloodbasedmarkersforearlystagebreastcancerdetection |
| _version_ |
1718423354014171136 |